(CNS) Cohen & Steers - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US19247A1007

Mutual Funds, Hedge Funds, Separate Accounts

CNS EPS (Earnings per Share)

EPS (Earnings per Share) of CNS over the last years for every Quarter: "2020-03": 0.42, "2020-06": 0.59, "2020-09": 0.66, "2020-12": -0.09, "2021-03": 1, "2021-06": 0.95, "2021-09": 1.05, "2021-12": 1.3, "2022-03": 0.85, "2022-06": 1.06, "2022-09": 0.9, "2022-12": 0.66, "2023-03": 0.71, "2023-06": 0.64, "2023-09": 0.65, "2023-12": 0.6, "2024-03": 0.68, "2024-06": 0.63, "2024-09": 0.77, "2024-12": 0.89, "2025-03": 0.77,

CNS Revenue

Revenue of CNS over the last years for every Quarter: 2020-03: 105.83, 2020-06: 94.087, 2020-09: 111.159, 2020-12: 116.46, 2021-03: 125.747, 2021-06: 144.269, 2021-09: 154.187, 2021-12: 159.629, 2022-03: 154.189, 2022-06: 147.431, 2022-09: 139.951, 2022-12: 127.827, 2023-03: 126.082, 2023-06: 120.986, 2023-09: 123.737, 2023-12: 116.863, 2024-03: 120.484, 2024-06: 121.574, 2024-09: 138.623, 2024-12: 144.731, 2025-03: 139.838,

Description: CNS Cohen & Steers

Cohen & Steers Inc (NYSE:CNS) is a global investment manager specializing in real assets and alternative income, operating through its subsidiaries to provide services to institutional investors, including pension funds, endowments, and foundations. The company manages a diverse range of portfolios, including equity, fixed income, multi-asset, and commodity investments, and launches mutual funds and hedge funds.

The firms investment strategy focuses on public equity, fixed income, and commodity markets worldwide, with a particular emphasis on the real estate sector, infrastructure, and natural energy resources. It also invests in preferred securities for its fixed income investments. With a strong track record since its founding in 1986, Cohen & Steers has established itself as a leading player in the asset management industry, with a presence in New York and a global reach.

Analyzing the available data, we can observe that the stock has experienced a decline in recent times, with the last price at $76.33, below its 20-day SMA of $78.67 and significantly lower than its 52-week high of $105.03. The current price is near its 50-day SMA, indicating a potential support level. However, the long-term trend remains bearish, as the stock is still far from its 200-day SMA of $87.28.

Using the available technical and fundamental data, a forecast can be made. Given the current P/E ratio of 25.45 and forward P/E of 25.13, the stock appears to be fairly valued. The RoE of 31.83% indicates a strong profitability profile. Considering the ATR of 1.84, representing a 2.41% daily volatility, and the current price near the 52-week low, a potential buying opportunity may arise if the stock demonstrates a strong reversal signal. A potential price target could be the 50-day SMA, and subsequently, the 200-day SMA, if the overall market sentiment improves and the firm continues to demonstrate strong financial performance.

Based on the analysis, it is essential to monitor the stocks price action and wait for a clear reversal signal before making any investment decisions. A thorough examination of the companys financials, management team, and industry trends is also necessary to determine the stocks potential for long-term growth.

Additional Sources for CNS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CNS Stock Overview

Market Cap in USD 3,935m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Asset Management & Custody Banks
IPO / Inception 2004-08-13

CNS Stock Ratings

Growth Rating 15.6
Fundamental 34.5
Dividend Rating 63.6
Rel. Strength -14.4
Analysts 4 of 5
Fair Price Momentum 71.90 USD
Fair Price DCF 22.48 USD

CNS Dividends

Dividend Yield 12m 2.97%
Yield on Cost 5y 4.16%
Annual Growth 5y 8.63%
Payout Consistency 84.0%
Payout Ratio 81.2%

CNS Growth Ratios

Growth Correlation 3m 32.3%
Growth Correlation 12m -43.4%
Growth Correlation 5y 46.4%
CAGR 5y 6.04%
CAGR/Max DD 5y 0.13
Sharpe Ratio 12m 0.14
Alpha 0.43
Beta 0.615
Volatility 30.77%
Current Volume 123.9k
Average Volume 20d 156.2k
What is the price of CNS shares?
As of July 05, 2025, the stock is trading at USD 78.01 with a total of 123,900 shares traded.
Over the past week, the price has changed by -0.13%, over one month by +3.00%, over three months by +3.80% and over the past year by +11.22%.
Is Cohen & Steers a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Cohen & Steers is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.48 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CNS is around 71.90 USD . This means that CNS is currently overvalued and has a potential downside of -7.83%.
Is CNS a buy, sell or hold?
Cohen & Steers has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CNS.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for CNS share price target?
According to our own proprietary Forecast Model, CNS Cohen & Steers will be worth about 81.6 in July 2026. The stock is currently trading at 78.01. This means that the stock has a potential upside of +4.63%.
Issuer Target Up/Down from current
Wallstreet Target Price 82.5 5.8%
Analysts Target Price 82.5 5.8%
ValueRay Target Price 81.6 4.6%